Clinical trials: Denovo Renal Transplantation
Denovo Renal Transplantation
Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids
All patients of the core study who are interested of being treated with EC-MPS will be included in an open-label extension study to collect further information on the long-term safety, tolerability and efficacy of this drug.
- Trial name
- NCT00239031
- Testing
- Enteric-Coated Mycophenolate Sodium
- Volunteers
- 117 people
- Sponsor
- Novartis